ピラゾリン基抗菌剤の設計と開発における進歩:最新情報と将来の見通し

Gourav Rakshit^1,2, Soumi Chakraborty¹, Sanjib Bhakta²

¹Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology Mesra Ranchi 835215 India venkatesanj@bitmesra.ac.in.

RSC advances

|September 3, 2025

まとめ

ピラゾリン化合物は,結核 (TB) および関連疾患の治療に有望である. このレビューでは,新しい強力な抗結核剤を開発するための化学的改変と戦略を考察します.

科学分野:

薬剤化学
薬物の発見
有機化学

背景:

ピラゾリンの支架は,様々な薬学的な活動のために認識されています.
ピラゾール誘導体は,様々な状態のために承認されているか,または臨床試験中である.
抗結核作用が研究されているピラゾリンは,チオアセタゾンの循環類である.

研究の目的:

ピラゾリンの抗結核活性に関する化学的宇宙探査を検討する.
効力を高めるための分子変化と戦略を強調する.
新型抗結核薬の開発のための洞察を提供すること.

主な方法:

ピラゾリン抗結核研究に焦点を当てた文献レビュー
分子改変,置換,結合の分析
in vitro/in silico標的相互作用とADMETの研究を含める

主要な成果:

抗結核活動のためのピラゾリン周辺の化学的変更の広範な調査.
InhAとP450を含むターゲット指向の戦略の特定
最近の特許,合成計画,評価モデルの概要

結論:

薬剤化学者はこのレビューを使用して,ピラゾリン抗結核薬の開発における研究ギャップを特定することができます.
結核 (TB),耐薬性結核 (DR-TB),非結核性ミコバクテリア疾患 (NTMD) に対する薬剤の合理的な設計に不可欠である.
ピラゾリンは菌根菌感染症と戦うための重要な基幹です

さらに関連する動画

07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.0K

11:51

Facile Preparation of 4-Substituted Quinazoline Derivatives

Published on: February 15, 2016

12.0K

関連する概念動画

01:11

Aryldiazonium Salts to Azo Dyes: Diazo Coupling

3.1K

The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the...

3.1K

01:25

Basicity of Heterocyclic Aromatic Amines

6.3K

Heterocyclic amines, where the N atom is a part of an alicyclic system, are similar in basicity to alkylamines. Interestingly, the heterocyclic amine having a nitrogen atom as part of an aromatic ring has much less basicity than its corresponding alicyclic counterpart. For this reason, as presented in Figure 1, piperidine (pKb = 2.8) is significantly more basic than pyridine (pKb = 8.8).

6.3K

01:28

Structure-Activity Relationships and Drug Design

1.0K

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

1.0K

01:27

Combined Effects of Drugs: Synergism

4.7K

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...